These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1911031)

  • 1. Toxicity and pharmacokinetics of morphine and morphine-6-glucuronide.
    Br J Anaesth; 1991 Sep; 67(3):362-3. PubMed ID: 1911031
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of morphine-6-glucuronide and morphine in healthy volunteers.
    Hanna MH; Peat SJ; Knibb AA; Fung C
    Br J Anaesth; 1991 Jan; 66(1):103-7. PubMed ID: 1997044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of morphine and morphine-6-glucuronide to respiratory depression in a child.
    Hannam JA; Anderson BJ
    Anaesth Intensive Care; 2012 Sep; 40(5):867-70. PubMed ID: 22934872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
    Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
    Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.
    Sverrisdóttir E; Lund TM; Olesen AE; Drewes AM; Christrup LL; Kreilgaard M
    Eur J Pharm Sci; 2015 Jul; 74():45-62. PubMed ID: 25861720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of morphine and morphine-6-glucuronide to the analgesic effect after morphine administration.
    Mikus G; Klimas R
    Br J Anaesth; 2015 Jun; 114(6):1007. PubMed ID: 25991747
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphine-6-glucuronide: morphine's successor for postoperative pain relief?
    van Dorp EL; Romberg R; Sarton E; Bovill JG; Dahan A
    Anesth Analg; 2006 Jun; 102(6):1789-97. PubMed ID: 16717327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased margin of safety of morphine-6-glucuronide relative to morphine.
    Romberg R; Olofsen E; Sarton E; Teppema L; Dahan A
    Anesthesiology; 2004 Jun; 100(6):1622; author reply 1622-3. PubMed ID: 15166596
    [No Abstract]   [Full Text] [Related]  

  • 10. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.
    Milne RW; Nation RL; Somogyi AA
    Drug Metab Rev; 1996 Aug; 28(3):345-472. PubMed ID: 8875123
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of pH on the buccal absorption of morphine sulphate and its major metabolite, morphine-3-glucuronide.
    Al-Sayed-Omar O; Johnston A; Turner P
    J Pharm Pharmacol; 1987 Nov; 39(11):934-5. PubMed ID: 2892919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pilot study of dose dependence in glucuronidation of morphine to morphine-3- and morphine-5-glucuronide].
    Friedrich G; Krieger A; Stritt W; Vach W
    Beitr Gerichtl Med; 1992; 50():215-20. PubMed ID: 1489328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects.
    Barratt DT; Klepstad P; Dale O; Kaasa S; Somogyi AA
    Pharmacogenomics J; 2024 Jun; 24(3):18. PubMed ID: 38824169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
    Lötsch J; Stockmann A; Kobal G; Brune K; Waibel R; Schmidt N; Geisslinger G
    Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nausea and morphine-6-glucuronide.
    Hagen NA; Foley KM; Cerbone DJ; Portenoy RK; Inturrisi CE
    J Pain Symptom Manage; 1991 Apr; 6(3):125-8. PubMed ID: 2016556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of intramuscularly administered nicomorphine (Vilan) with its metabolites and their glucuronide conjugates in surgical patients.
    Koopman-Kimenai PM; Vree TB; Booij LH; Dirksen R
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):442-8. PubMed ID: 8556223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem redistribution of morphine and its metabolites.
    Gerostamoulos J; Drummer OH
    J Forensic Sci; 2000 Jul; 45(4):843-5. PubMed ID: 10914581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological excitation in a 6-week-old male infant after morphine overdose.
    Thomas J; Corson NI; Meinhold A; Both CP
    Paediatr Anaesth; 2019 Oct; 29(10):1060-1061. PubMed ID: 31433900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sedation in intensive care: morphine and renal failure.
    Park GR; Shelly MP; Manara AR; Quinn K
    Intensive Care Med; 1987; 13(5):365-7. PubMed ID: 3655108
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer.
    Mashayekhi SO; Ghandforoush-Sattari M; Routledge PA; Hain RD
    Biopharm Drug Dispos; 2009 Apr; 30(3):99-106. PubMed ID: 19260034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.